Preliminary indications in Mali from the first trial for an Ebola vaccine taking place in Africa seem promising. “We know that after two weeks they’re starting to have some immune response and there are no adverse reactions,” says Dr Samba Sow, an infectious disease epidemiologist and vaccine expert and director of Centre for Vaccine Development (CVD) in Mali.

READ FULL ARTICLE Curated publisher From BBC Travel Passport blog